Clinical trial Recruiting at 1 site Observational Ages 18 and up

Effects of cross-sex hormone therapy on metabolism and eating behavior

Official title: Investigation of the Effects of Testosterone and Estrogen on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System in Transsexual Patients Undergoing Cross-sex Hormone Therapy

Run by University of Leipzig · NCT04838249 · Data updated 2026-11-12

This study looks at how cross-sex hormone therapy affects metabolism, eating habits, and overall health in people undergoing this treatment.

More Arterial Stiffness trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity of Leipzig
Academic / other
Locations1 site (Leipzig, Saxony)
StatusRecruiting
StartedMay 5, 2021
Main results expectedMay 2026
Study endsMay 2026
Registry record updatedDecember 5, 2025
Trial IDNCT04838249 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are transsexual patients undergoing cross-sex hormone therapy who are weight stable and have a BMI of 30 kg/m2 or less.

Probably not a fit

Patients with severe medical impairments or those who have self-initiated cross-sex hormone therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the interconnected physiological systems in patients undergoing cross-sex hormone therapy, focusing on glucose and lipid metabolism, energy balance, eating behavior, and cardiovascular health. It seeks to gather insights into how sex hormones influence these systems and their potential role in overeating, obesity, insulin resistance, and cardiovascular disease. Additionally, the study will investigate the relationships between gut and oral microbiomes and their impact on these physiological systems.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the health impacts of cross-sex hormone therapy, potentially improving treatment strategies for transgender individuals.

How similar studies have gone: While there is limited data on the specific effects of cross-sex hormone therapy on these physiological systems, similar studies have shown promising results in understanding hormonal impacts on metabolism and cardiovascular health.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* transsexual patients undergoing cross-sex hormone therapy versus controls
* able to give informed consent, if \<18 years from all legal guardians
* only for part B (patients will participate in all other study parts): weight stable (± 5%) for last 3 months, BMI ≤ 30 kg/m2

Exclusion Criteria:

* severe medical impairments (e.g., uncontrolled cardiovascular disease, severe heart failure, uncontrolled hypertension, cerebral insult, active malign disease, etc.)
* self-initiated cross-sex hormone therapy before study start only for part B (patients will participate in all other study parts): Insufficiently controlled endocrine disorders (Cushing's disease, other uncontrolled pituitary disorders, uncontrolled hypothyroidism, hyperthyroidism, etc.)
* Chronic pulmonary disorders, including chronic obstructive pulmonary disease that would limit ability to follow the protocol (investigator judgment) and obstructive sleep apnea syndrome; only subjects with mild or exercise-induced asthma on no medications or on beta-adrenergic agonists only will be allowed to enter the study (provided use of these agents is not required for 1 week before
* Diagnosed gastrointestinal diseases, including inflammatory bowel diseases (e.g. Crohn's disease and ulcerative colitis), malabsorption syndromes (e.g. celiac disease), gastric ulcer (active); only subjects with gastro-esophageal reflux will be allowed to enter the study entry).
* History of HIV infection or ongoing chronic infection (such as tuberculosis)
* only for part D (patients will participate in all other study parts): Contraindication against performance of an MRI scan (i.e., presence of metal in body, tattoos in head/neck region, claustrophobia etc.)

Where it's running

  • Helmholtz Institute for Metabolic, Obesity and Vascular Research
    Leipzig, Saxony, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.